AbbVie Collaborates With ADARx Pharma To Develop Next-Generation SiRNA Therapies
14/5 15:14
(RTTNews) - AbbVie Inc. (ABBV) and ADARx Pharmaceuticals, Wednesday announced a collaboration and license option agreement to develop small interfering RNA or siRNA therapeutics across multiple disease areas including neuroscience, immunology and oncology....